|
HS Code |
988461 |
| Product Name | (S)-N-Fmoc-3-Thienylalanine |
| Chemical Formula | C20H17NO3S |
| Molecular Weight | 351.42 g/mol |
| Cas Number | 162870-27-7 |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Optical Purity | S-enantiomer (L-form) |
| Protecting Group | Fmoc (9-fluorenylmethyloxycarbonyl) |
| Smiles | O=C(N[C@@H](Cc1ccsc1)C(=O)O)OCC2c3ccccc3-c4c2cccc4 |
| Application | Peptide synthesis |
As an accredited (S)-N-Fmoc-3-Thienylalanine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The chemical is packaged in a sealed amber glass bottle containing 5 grams, clearly labeled with the product name and safety information. |
| Shipping | (S)-N-Fmoc-3-Thienylalanine is typically shipped at ambient temperature, securely packed to prevent moisture and light exposure. It is transported in sealed containers, compliant with chemical regulations. Shipping includes safety labeling and documentation, ensuring safe handling and traceability during transit. Express or standard delivery options may be available based on destination. |
| Storage | (S)-N-Fmoc-3-Thienylalanine should be stored in a tightly sealed container, protected from light, moisture, and excessive heat. Keep it in a cool, dry place, ideally at 2–8°C (refrigerated). Avoid exposure to strong acids, bases, and oxidizing agents. Proper storage ensures the chemical’s stability and integrity for laboratory and synthetic applications. |
Applications of (S)-N-Fmoc-3-Thienylalanine in Industrial Manufacturing(S)-N-Fmoc-3-Thienylalanine serves as a critical protected amino acid in advanced peptide synthesis and pharmaceutical intermediate production. As the original manufacturer, we integrate strict QC protocols and supply consistent batches for these specialized applications, supporting downstream manufacturing partners in regulated industries. 1. Peptide Active Pharmaceutical Ingredients (APIs) SynthesisPharmaceutical companies widely incorporate (S)-N-Fmoc-3-Thienylalanine into solid-phase peptide synthesis processes for small-molecule API development, especially when introducing thiophene-based side chains for novel bioactivity. This raw material supports GMP-compliant synthesis of custom peptides intended for oncology research, metabolic disorder treatments, and diagnostic imaging agents. Strict documentation verifies traceability of every lot to support regulatory audits and DMF submissions. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptidomimetic Drug DiscoveryDrug discovery groups in the pharmaceutical sector rely on (S)-N-Fmoc-3-Thienylalanine as a structural element for generating libraries of peptidomimetics, enhancing compound stability and increasing binding specificity to protein targets. This amino acid’s thiophene ring supports structural diversity in lead optimization efforts, particularly for protease inhibitors and signaling pathway modulators subjected to preclinical screening and patent protection strategies. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Diagnostic Peptide Reagent ManufacturingManufacturers of in vitro diagnostic kits use (S)-N-Fmoc-3-Thienylalanine in the synthesis of labeled peptides or peptide substrates designed for selectivity in clinical enzyme assays, immunoassays, and affinity-based detection platforms. Kit producers demand traceable batches and data confirming peptide sequence fidelity to meet regulatory and customer validation requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Bioconjugate and Antibody-Drug Conjugate (ADC) Intermediate ProductionADC manufacturers use (S)-N-Fmoc-3-Thienylalanine for segmental incorporation into linker peptides, supporting the site-specific attachment of payloads to monoclonal antibodies. The thiophene-modified amino acid enables tailored conjugation chemistry, improving pharmacokinetic profiles and controlled drug release, while facilitating quality control throughout pilot and cGMP manufacturing campaigns. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Custom Peptide Reagent Synthesis for Research InstitutionsAcademic and industrial peptide contract research organizations order batches containing this Fmoc-protected amino acid for projects requiring site-specific incorporation of thiophene-motif residues into target peptides, primarily for research on protein-protein interactions, structural analysis, and ligand-receptor mapping. We guarantee individualized batch documentation and process support for institutional research compliance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive (S)-N-Fmoc-3-Thienylalanine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our chemical plant, steady hands manage the critical early stages of peptide assembly. Every day, our teams handle raw materials, watch reactions, and inspect the final output to ensure consistent results for our partners in biotech and pharmaceutical research. Among the building blocks we prepare, (S)-N-Fmoc-3-Thienylalanine has become a product we trust ourselves. Over years of production, we have become familiar with its quirks and strong points, and we continue to refine our approach based on feedback and direct lab experience.
(S)-N-Fmoc-3-Thienylalanine, often abbreviated in the lab as Fmoc-3-ThienylAla, offers a unique aromatic side chain derived from the thiophene ring. This S-configured, Fmoc-protected alpha-amino acid has proven valuable for researchers designing custom peptides that call for both rigidity and electronic diversity unavailable from natural amino acids. The thienyl side chain brings a distinct π-system into peptide backbones, opening new avenues for influencing both structure and function of peptides in drug discovery or material science experiments.
Our plant focuses on chiral purity and precise protection—without these priorities, synthetic results waver. The Fmoc group permits solid-phase peptide synthesis, protecting the amino group until the chain grows long enough for deprotection and coupling. Experienced chemists recognize the difference when side chain variations appear; for (S)-N-Fmoc-3-Thienylalanine, the planarity and electron-rich nature of the thiophene ring set it apart in terms of stacking, hydrogen bonding, and reactivity.
Large-scale manufacturing of advanced amino acids only pays off with careful quality oversight. Since our plant specializes in enantioselective processes, we work with solvents, bases, and catalysts that never stray from accepted specs. Fmoc protection steps bring their own pitfalls: side reactions, especially overprotection or unwanted migration, show up most when pressure rises during upscaling. Our teams tackle these by checking purity at multiple points through HPLC, NMR, and mass spectrometry, not just at the end.
We respond fast to requests for custom lots, because researchers sometimes require larger batches or narrower specifications. Sometimes an academic project needs less than a gram at ultimate purity. In other cases, a pharma collaborator will need several kilograms supported with extensive documentation, traceability, and repeat analysis. We can shift scale based on demand, with tanks, glassware, and support gear sized for both extremes.
Our customers describe a range of projects—peptidomimetic design, labeled peptides, solid-state sensor substrates, and high-density peptide arrays. This modified amino acid fits where natural alternatives fall short. Peptide scientists are rarely interested in easy substitutions: the sulfur atom in the thiophene ring allows electron mobility, impacting binding in enzyme targets and stacking in β-sheets. For medicinal chemistry, introducing a thienyl moiety can modulate hydrophobicity and increase metabolic stability. We have seen peptides incorporating Fmoc-3-ThienylAla exhibit shifted retention times and unique activity profiles, particularly when researchers aim to disrupt protein-protein interactions.
On the production floor, we see firsthand how important reliable supply is. Gaps in delivery or suspected inconsistencies in chirality create bottlenecks for research teams down the chain. Because of this, our plant continuously invests in staff training and process upgrades. We maintain controlled environments—humidity, temperature, filtration—so that both initial synthesis and recrystallization remain steady. Granular data from batch records catch issues before any material leaves our hands.
Peptide chemists may reach for other aromatic amino acids—such as Fmoc-Phenylalanine or Fmoc-Tryptophan—but the thienyl side chain gives (S)-N-Fmoc-3-Thienylalanine a distinct electronic signature. The aromatic thiophene absorbs light differently, and its non-benzenoid structure lets it participate in interactions unavailable to phenyl or indole systems. In our own evaluations, peptides with thienyl substituents sometimes demonstrate unexpected folding, or altered solubility in organic solvents. This attribute has made a difference for clients working on signal amplification tags or stabilization features.
Fmoc-protected amino acids as a broader class remain the workhorses of solid-phase peptide synthesis, but the difference between standard building blocks and unique ones like Fmoc-3-ThienylAla stands out in practical settings. Scientists seeking to disrupt conformational patterns or encode recognition motifs have only a limited toolbox—our job as a manufacturer is to keep that toolbox sharp, with reliable, pure, and well-characterized materials. Past collaborations have shown us that the presence of even traces of epimers causes synthetic failures or confounding biological results. By adhering to chiral analysis protocols and sampling regimes, our plant keeps these issues outside customer sightlines.
Producing alpha-amino acids with electron-rich heterocycles has its stumbling blocks. The initial alkylation of the thienyl group, if not kept dry and atmosphere-free, creates unwanted byproducts. Sometimes the thiophene ring reacts in side reactions not seen with phenyl or benzyl groups. We learned over years that high-purity nitrogen flow, selectivity-focused phase transfer conditions, and careful TLC monitoring avoid most yield drops.
During the Fmoc protection phase itself, the tendency for overreaction in the presence of excess base must be monitored with real-time pH and residue measurements. Each operator undergoes cross-training to spot evidence of incomplete protection or unexpected adducts, both visually during crystallization and later by UV and HPLC checks. With batch-to-batch tightness, we help researchers avoid the guesswork of troubleshooting peptide loading failures. Where others struggle with scale-up faults or loss of chiral purity, we see fewer inconsistencies due to strict in-process control.
Trust comes from more than claims—it’s built on data. Each shipment includes a detailed certificate of analysis, with chromatography traces and spectral records. By request, we offer full impurity profiles, including minor stereoisomer content, expected and unexpected byproducts, and residual solvent levels. Clients often require extra documentation for regulatory filings or publication support, and our staff prepares these custom data packs with access to raw test input.
We do not reserve the best controls for our own use; everything we ship out passes the same inspection as samples used for internal reference. Our analysts use orthogonal techniques: mass spectrometry confirms molecular mass, NMR provides structure, and chiral HPLC quantifies both purity and enantiomeric excess. The comprehensive approach, rather than shortcuts, forms the basis of our product assurance. Any deviation—even slight—is recorded, and clients notified before shipping. This transparency builds mutual understanding and reduces surprises months down the line.
Down the years, we’ve handled thousands of sealed Fmoc-amino acid jars. For (S)-N-Fmoc-3-Thienylalanine, experience says: keep it dry, cool, and away from direct light. The thienyl ring, though robust in peptide assemblies, can take on trace oxidation under high humidity. Shelf life depends more on storage discipline than any magic preservative. Each container includes a desiccant packet and a quality seal; we recommend usage under inert atmosphere if the entire batch won’t be consumed immediately.
For large volume users, our technical advisors can help review handling routines. Spatulas, scoops, and weighing paper pick up static charges, sometimes attracting fine Fmoc powders and skewing weights. Where labs process multiple acids in parallel, thorough washing and tracking prevents contamination risk. We share tips collected from our own labs and customer feedback orders: color checks under UV lamp, quick dissolution trials in DMF, and pre-coupling test batches to verify loading and side reaction profiles.
Some chemists, new to peptide design, think a simple swap between Fmoc-3-Thienylalanine and Fmoc-Phenylalanine will not affect outcomes. Our own mixed peptide screenings tell us otherwise. Thiophene’s sulfur atom alters the electron density and, in certain solvents, changes peptide folding or even facilitates new disulfide-like contacts in cysteine-free systems. Even minor adjustments in packing density or UV absorption have led to real-world differences in experimental readouts. These features inspire repeat orders when teams want to make their peptides more distinctive or escape patent thickets tied to standard amino acids.
Just as important, (S)-N-Fmoc-3-Thienylalanine remains less prone to oxidative side reactions than Fmoc-Tryptophan. Peptide chains prone to indole decomposition under strong acid conditions may fare better using thienyl-substituted analogues. We have monitored chain integrity during TFA cleavage, finding fewer color changes and reduced side-product interference than with indole-containing peptides. Chemists looking to improve yield at the final deprotection—especially in sensitive or multi-step syntheses—find this matters.
Markets for peptide research shift quickly. Five years ago, few requests came for thienylalanine at kilogram scale; that changed as drug and sensor projects needed less explored side chains to drive innovation. Our R&D and production teams talk directly with end users—not only purchasing teams but bench scientists, synthetic chemists, and regulatory officers. We hear about reaction failures, modification requests, and performance notes within days of delivery, not through layers of intermediaries.
This direct line means continual tuning. Process engineers keep logs of yield-dragging steps and push for improvements: more efficient extractions, safer waste handling for the thiophene ring, automated reaction monitoring, and tighter solvent specs. Even changes in source materials can have a ripple effect; our sourcing teams hold long relationships with primary suppliers, so traceability extends to every raw batch that enters our facility.
Peptide research only advances when every hand in the process is steady. As a direct manufacturer, we take pride in our responsibility to the chemists depending on us; shortcuts or ambiguous communication undermine progress for entire projects. We offer advice to newcomers and seasoned peptide specialists, informed by the cumulative experience of our technical staff. Sometimes researchers contact us for troubleshooting—a failed coupling, a strange shift in retention time, or a question about purification. We respond with action plans, not boilerplate: is the resin exposure at fault? Has the Fmoc group hydrolyzed? Is there off-target reactivity seen with unusual assay conditions? These questions come directly to our technical team, who use in-house experience and shared knowledge gleaned from years of batch work.
The world of synthetic biology, material science, and modern medicine depends on compounds that do more than fill catalog pages. Every order—large or small—traces back to a real need, a bench experiment, or an instrument calibration that cannot afford unreliable sourcing. Being part of this chain, we hold our practices to higher standards, using not only state-of-the-art equipment but also the practiced judgment of technicians who have seen multiple years of process complexities. Regulatory compliance and lab safety are part of our daily routines, not afterthoughts.
Traders, distributors, and resellers all play a role in expanding access to specialty chemicals. Yet, the direct connection between manufacturer and researcher has value beyond pricing. By cutting out steps and keeping feedback loops short, mistakes are fixed faster, and real needs surface clearly. When excess moisture in an overseas shipment once caused a minor impurity spike, our team traced the incident, shipped a new batch, and adjusted our export packaging—all within days. This kind of accountability grows mutual trust and enables innovation.
For about two decades, our plant has watched demand for non-natural amino acids swing wildly, reflecting scientific trends in academia, pharma, and materials engineering. With each order of (S)-N-Fmoc-3-Thienylalanine, we see how a careful approach—combining precise synthesis, in-depth analytical work, and a direct relationship with end-users—enables scientists to break new ground. As new applications emerge, we stay ready to adjust, advise, and provide the materials necessary for successful research and production.
Manufacturing (S)-N-Fmoc-3-Thienylalanine is more than a routine synthesis. It requires constant vigilance, technical skill, and honest communication to maintain the quality and reliability researchers expect. Through years of batch work, on-the-ground troubleshooting, and open exchanges with the scientific community, we have shaped our process to deliver value that extends far beyond the molecular level. The goal remains clear: provide researchers the right tools, with the highest standards, so new discoveries can unfold without unnecessary obstacles. We look forward to supporting the next round of peptide innovation, grounded in experience and built on trust.